Cargando…

The impact of marginal lung function on outcomes in the era of minimally invasive thoracic surgery

BACKGROUND: The effect of marginal lung function on outcomes after lung resection has traditionally been studied in the context of open thoracic surgery. Its impact on postoperative outcomes in the era of minimally invasive lung resection is unclear. METHODS: In this retrospective cohort study, we i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakahama, Hiroko, Jaradeh, Mark, Abdelsattar, Zaid M., Lubawski, James, Vigneswaran, Wickii T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743406/
https://www.ncbi.nlm.nih.gov/pubmed/35070364
http://dx.doi.org/10.21037/jtd-21-1382
_version_ 1784629896877703168
author Nakahama, Hiroko
Jaradeh, Mark
Abdelsattar, Zaid M.
Lubawski, James
Vigneswaran, Wickii T.
author_facet Nakahama, Hiroko
Jaradeh, Mark
Abdelsattar, Zaid M.
Lubawski, James
Vigneswaran, Wickii T.
author_sort Nakahama, Hiroko
collection PubMed
description BACKGROUND: The effect of marginal lung function on outcomes after lung resection has traditionally been studied in the context of open thoracic surgery. Its impact on postoperative outcomes in the era of minimally invasive lung resection is unclear. METHODS: In this retrospective cohort study, we included adult patients who underwent minimally invasive lung resection at our institution between January 2017 and May 2020 for known malignancy or lung nodule. Marginal lung function was defined as pre-operative forced expiratory volume in 1 second (FEV1) and/or diffusion lung capacity of carbon monoxide <60% of predicted. Our outcomes included a composite outcome of pulmonary morbidity and/or 30- and 90-day mortality, and hospital length of stay. We used multivariable logistic and Poisson regression models to identify associations with outcomes, and Kaplan-Meier and Cox models to estimate survival. RESULTS: Of 300 patients, 88 (29%) had marginal lung function. Patients in the marginal group were more likely to be female (69% vs. 56%; P=0.028), and more likely to have: hypertension (HTN) (83% vs. 71%; P=0.028), chronic obstructive pulmonary disease (COPD) (38% vs. 12%; P<0.001), interstitial lung disease (ILD) (9% vs. 3%; P<0.019), and ischemic heart disease (28% vs. 18%; P=0.033). Patients were similar in terms of age (68±8 vs. 68±10 years; P=0.932), and other comorbidities. Anatomic lung resection comprised 56.8% of the marginal group vs. 74% in the non-marginal group (P=0.003). The most common complication was prolonged air leak (18.2% vs. 11.8%; P=0.479). Marginal lung function had a trend toward increased composite respiratory complications (22.7% vs. 15.1%; P=0.112) and 90-day mortality (5.7% vs. 4.2%; P=0.591), although they did not reach statistical significance. There was a statistically significant 1-day average increase in length of stay in the marginal lung function cohort (4.6 vs. 3.4 days; P<0.015) with a stronger association with diffusion lung capacity of carbon monoxide than FEV1. Survival was similar (marginal function HR =1.0; P=0.994). CONCLUSIONS: In the era of minimally invasive thoracic surgery, lung resection in patients with marginal lung function may be considered in select patients. These findings aid in the selection consideration and counseling of this patient population.
format Online
Article
Text
id pubmed-8743406
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87434062022-01-21 The impact of marginal lung function on outcomes in the era of minimally invasive thoracic surgery Nakahama, Hiroko Jaradeh, Mark Abdelsattar, Zaid M. Lubawski, James Vigneswaran, Wickii T. J Thorac Dis Original Article BACKGROUND: The effect of marginal lung function on outcomes after lung resection has traditionally been studied in the context of open thoracic surgery. Its impact on postoperative outcomes in the era of minimally invasive lung resection is unclear. METHODS: In this retrospective cohort study, we included adult patients who underwent minimally invasive lung resection at our institution between January 2017 and May 2020 for known malignancy or lung nodule. Marginal lung function was defined as pre-operative forced expiratory volume in 1 second (FEV1) and/or diffusion lung capacity of carbon monoxide <60% of predicted. Our outcomes included a composite outcome of pulmonary morbidity and/or 30- and 90-day mortality, and hospital length of stay. We used multivariable logistic and Poisson regression models to identify associations with outcomes, and Kaplan-Meier and Cox models to estimate survival. RESULTS: Of 300 patients, 88 (29%) had marginal lung function. Patients in the marginal group were more likely to be female (69% vs. 56%; P=0.028), and more likely to have: hypertension (HTN) (83% vs. 71%; P=0.028), chronic obstructive pulmonary disease (COPD) (38% vs. 12%; P<0.001), interstitial lung disease (ILD) (9% vs. 3%; P<0.019), and ischemic heart disease (28% vs. 18%; P=0.033). Patients were similar in terms of age (68±8 vs. 68±10 years; P=0.932), and other comorbidities. Anatomic lung resection comprised 56.8% of the marginal group vs. 74% in the non-marginal group (P=0.003). The most common complication was prolonged air leak (18.2% vs. 11.8%; P=0.479). Marginal lung function had a trend toward increased composite respiratory complications (22.7% vs. 15.1%; P=0.112) and 90-day mortality (5.7% vs. 4.2%; P=0.591), although they did not reach statistical significance. There was a statistically significant 1-day average increase in length of stay in the marginal lung function cohort (4.6 vs. 3.4 days; P<0.015) with a stronger association with diffusion lung capacity of carbon monoxide than FEV1. Survival was similar (marginal function HR =1.0; P=0.994). CONCLUSIONS: In the era of minimally invasive thoracic surgery, lung resection in patients with marginal lung function may be considered in select patients. These findings aid in the selection consideration and counseling of this patient population. AME Publishing Company 2021-12 /pmc/articles/PMC8743406/ /pubmed/35070364 http://dx.doi.org/10.21037/jtd-21-1382 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Nakahama, Hiroko
Jaradeh, Mark
Abdelsattar, Zaid M.
Lubawski, James
Vigneswaran, Wickii T.
The impact of marginal lung function on outcomes in the era of minimally invasive thoracic surgery
title The impact of marginal lung function on outcomes in the era of minimally invasive thoracic surgery
title_full The impact of marginal lung function on outcomes in the era of minimally invasive thoracic surgery
title_fullStr The impact of marginal lung function on outcomes in the era of minimally invasive thoracic surgery
title_full_unstemmed The impact of marginal lung function on outcomes in the era of minimally invasive thoracic surgery
title_short The impact of marginal lung function on outcomes in the era of minimally invasive thoracic surgery
title_sort impact of marginal lung function on outcomes in the era of minimally invasive thoracic surgery
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743406/
https://www.ncbi.nlm.nih.gov/pubmed/35070364
http://dx.doi.org/10.21037/jtd-21-1382
work_keys_str_mv AT nakahamahiroko theimpactofmarginallungfunctiononoutcomesintheeraofminimallyinvasivethoracicsurgery
AT jaradehmark theimpactofmarginallungfunctiononoutcomesintheeraofminimallyinvasivethoracicsurgery
AT abdelsattarzaidm theimpactofmarginallungfunctiononoutcomesintheeraofminimallyinvasivethoracicsurgery
AT lubawskijames theimpactofmarginallungfunctiononoutcomesintheeraofminimallyinvasivethoracicsurgery
AT vigneswaranwickiit theimpactofmarginallungfunctiononoutcomesintheeraofminimallyinvasivethoracicsurgery
AT nakahamahiroko impactofmarginallungfunctiononoutcomesintheeraofminimallyinvasivethoracicsurgery
AT jaradehmark impactofmarginallungfunctiononoutcomesintheeraofminimallyinvasivethoracicsurgery
AT abdelsattarzaidm impactofmarginallungfunctiononoutcomesintheeraofminimallyinvasivethoracicsurgery
AT lubawskijames impactofmarginallungfunctiononoutcomesintheeraofminimallyinvasivethoracicsurgery
AT vigneswaranwickiit impactofmarginallungfunctiononoutcomesintheeraofminimallyinvasivethoracicsurgery